(Q48220483)

9 February 2018

title

Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke. (English)

1 reference

9 February 2018

1 reference

S M Lew

1

1 reference

9 February 2018

C E Gross

2

1 reference

9 February 2018

M M Bednar

3

1 reference

9 February 2018

S J Russell

4

1 reference

9 February 2018

S P Fuller

5

1 reference

9 February 2018

C L Ellenberger

6

1 reference

9 February 2018

D Howard

7

1 reference

9 February 2018

publication date

1 February 1999

1 reference

9 February 2018

published in

Brain Research Bulletin

1 reference

9 February 2018

volume

48

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

325-331

1 reference

9 February 2018

Tissue plasminogen activator for acute ischemic stroke

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

MEASUREMENT OF LOCAL BLOOD FLOW WITH HYDROGEN GAS

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Neutrophil and Platelet Activity and Quantification Following Delayed tPA Therapy in a Rabbit Model of Thromboembolic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Comparison of triphenyltetrazolium dye with light microscopic evaluation in a rabbit model of acute cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Antineutrophil strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Neutrophil activation in acute human central nervous system injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Humanized anti-L-selectin monoclonal antibody DREG200 therapy in acute thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Tissue plasminogen activator: comparison of dose and route of administration in a rabbit model of thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

The role of neutrophils and platelets in a rabbit model of thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

IB4, a monoclonal antibody against the CD18 leukocyte adhesion protein, reduces intracranial pressure following thromboembolic stroke in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Activation of the complement system by recombinant tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Is there a case for PAF antagonists in the treatment of ischemic states?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Influence of granulocytopenia on canine cerebral ischemia induced by air embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Arachidonic acid and its metabolites during cerebral ischemia and recirculation. Pharmacological interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Systemic complement depletion inhibits experimental cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Experimental antileukocyte interventions in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Terminal complement complexes and anaphylatoxins in septic and ischemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Effects of complement activation in the isolated heart. Role of the terminal complement components

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Prolongation of cardiac xenograft survival by depletion of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Effects of decomplementation with cobra venom factor on experimental vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Role of Neutrophils in Radical Production during Ischemia and Reperfusion of the Rat Brain: Effect of Neutrophil Depletion on Extracellular Ascorbyl Radical Formation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Circulatory responses to ketamine: dependence on respiratory pattern and background anaesthesia in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Complement localization and mediation of ischemic injury in baboon myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Complement depletion improves neurological function in cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

The effect of postischemic blood glucose levels on ischemic brain damage in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

H2 clearance measurement of blood flow: a review of technique and polarographic principles

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2899%2900004-0

7 January 2021

10.1016/S0361-9230(99)00004-0

Identifiers

DOI

1 reference

9 February 2018

release_wkaexcxr35atvnq6rrhlctyvty

Fatcat ID

0 references

PubMed ID

10229342

1 reference

9 February 2018